BDPI USP - Resultado da busca

Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway (2017)

Roversi, Fernanda Marconi; Pericole, Fernando Vieira; Machado Neto, João Agostinho; Duarte, Adriana da Silva Santos; Longhini, Ana Leda; Corrocher, Flavia Adolfo; Palodetto, Bruna; Ferro, Karla Priscila; Rosa, Renata Giardini; Baratti, Mariana Ozello; Verjovski-Almeida, Sérgio; Traina, Fabiola; Molinari, Alessio; Botta, Maurizio; Saad, Sara Teresinha Olalla

In: Biochimica et Biophysica Acta. Unidades: IQ, FMRP

Subjects: Leucemia Mieloide Aguda, Células-tronco

Acesso à fonte DOI

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
ROVERSI, Fernanda Marconi; PERICOLE, Fernando Vieira; MACHADO NETO, João Agostinho; et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochimica et Biophysica Acta, Amsterdam, v. 1863, n. 2, p. 450-461, 2017. Disponível em: < http://dx.doi.org/10.1016/j.bbadis.2016.11.013 > DOI: 10.1016/j.bbadis.2016.11.013.
APA
Roversi, F. M., Pericole, F. V., Machado Neto, J. A., Duarte, A. da S. S., Longhini, A. L., Corrocher, F. A., et al. (2017). Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochimica et Biophysica Acta, 1863( 2), 450-461. doi:10.1016/j.bbadis.2016.11.013
NLM
Roversi FM, Pericole FV, Machado Neto JA, Duarte A da SS, Longhini AL, Corrocher FA, Palodetto B, Ferro KP, Rosa RG, Baratti MO, Verjovski-Almeida S, Traina F, Molinari A, Botta M, Saad STO. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway [Internet]. Biochimica et Biophysica Acta. 2017 ; 1863( 2): 450-461.Available from: http://dx.doi.org/10.1016/j.bbadis.2016.11.013
Vancouver
Roversi FM, Pericole FV, Machado Neto JA, Duarte A da SS, Longhini AL, Corrocher FA, Palodetto B, Ferro KP, Rosa RG, Baratti MO, Verjovski-Almeida S, Traina F, Molinari A, Botta M, Saad STO. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway [Internet]. Biochimica et Biophysica Acta. 2017 ; 1863( 2): 450-461.Available from: http://dx.doi.org/10.1016/j.bbadis.2016.11.013

ReP

Filters

USP Schools

ReP

Filters

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Keywords